TBIO
Telesis Bio, Inc. Common Stock
TBIO
TBIO
Delisted
TBIO was delisted on the 27th of September, 2024.
25 hedge funds and large institutions have $12.3M invested in Telesis Bio, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
61% less call options, than puts
Call options by funds: $32K | Put options by funds: $83K
Holders
25
Holding in Top 10
1
Calls
$32K
Puts
$83K
Top Buyers
| 1 | +$30K | |
| 2 | +$11.2K | |
| 3 | +$10.9K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$6.76K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$6K |
Top Sellers
| 1 | -$146K | |
| 2 | -$29.4K | |
| 3 | -$21.9K | |
| 4 |
Millennium Management
New York
|
-$12.7K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$12K |